📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Realising the full potential of MR-PHeWAS in cancer. (2021)

First Author: Bowden J

Attributed to: Pleiotropy robust Mendelian randomization funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41416-020-01165-0

PubMed Identifier: 33235313

Publication URI: http://europepmc.org/abstract/MED/33235313

Type: Journal Article/Review

Volume: 124

Parent Publication: British journal of cancer

Issue: 3

ISSN: 0007-0920